SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (254)2/24/1999 12:58:00 AM
From: Pseudo Biologist  Read Replies (1) | Respond to of 1127
 
Thanks, this is complicated indeed. The following states that VEGF-2 (HGS's name for the molecule) is the same as VEGF-C:

ncbi.nlm.nih.gov

And yes, not clear at all that VEGF-2 should be any better, as a protein or as gene therapy. Too early to tell.

PB


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News